OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is a micro-cap medical marijuana play that has started to find some major renewed momentum in recent days. This has been one of the most impressive plays in the space, at one time rising as much as 4,600% in just a 5-week period.
If there is one lesson we keep harping on time and time again throughout this post-election period for all stocks even remotely related to the cannabis business, it’s this: the market will reward investment. There is an almost guarantee of a high ROI response from the market. That means, capital raises, new ground broken on projects for facilities, new leased space, new equipment. Anything that represents capital put to work to expand market share. It’s going to work. We’ve seen it with several stocks. OWCP may be tapping into the same energy in its latest 8K, which we will discuss below. But first, allow us to refresh your acquaintance with this company.
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) bills itself as a company that engages in the research and development of Cannabis-based medical products. The company provides medical products for the treatment of various medical conditions and/or diseases, such as multiple myeloma, psoriasis, PTSD, and migraines; and delivery systems. It also provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations.
OWCP through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals, treatments and unique delivery systems for the effective delivery and dosage of medical cannabis.
All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.
The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. The company was formerly known as Dynamic Applications Corp. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Petach Tikva, Israel.
Find out when $OWCP stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
According to the company’s 8K out on Thursday of this past week, “On November 22, 2016, OWC Pharmaceutical Research Corp. filed a Form 8-K reporting that it had entered into a Reg S Unit Subscription Agreement with Michepro Holding Ltd, organized under the laws of Cyprus, pursuant to which the Investor subscribed for and purchased the Registrant’s securities for cash consideration of $300,000.
“In connection with the Reg S Subscription Agreement with Michepro, the Registrant also entered into a Corporate Management Services Agreement, a copy of which is attached as Exhibit 10.19 hereto, with Sorelenco Limited, organized under the laws of Cyprus, and an affiliate of Michepro, pursuant to which the Consultant agreed to provide management services to a new entity being organized by the Registrant, OWC Europe Marketing Corporation. The Consultant shall provide OWC Europe with services involving the day to day operations of OWC Europe including, but not limited to management, business development, sales and marketing of the products of the Registrant’s wholly-owned Israeli subsidiary, One World Cannabis Ltd and the hiring and training of staff, among other services.”
The filing continues, noting that, “On December 16, 2016, the Registrant entered into a Consulting Agreement with Jeff Smurlick, a resident of the State of Florida, pursuant to which the Consultant shall provide the Registrant with services in the areas of investor relations and business development with the objective of generating interest in the business of the Registrant and its subsidiary, including assisting the Registrant in establishing relationships with the financial and medical communities specializing in the field of medical cannabis as well as with the general media which includes an investor relations (IR) program for the Company. A copy of the Consulting Agreement is attached as Exhibit 10.20 hereto. In consideration for the services, the Registrant issued to the Consultant 200,000 Class G Warrants and 200,000 Class H Warrants identical to the Class G and Class H Warrants described above.”
Traders will note 54% piled on for shareholders of the stock during the trailing month.
Currently trading at a market capitalization of $21.2M, OWCP has an extremely small store of cash on the books, which must be weighed relative to an extremely limited amount of total accumulated debt. While this is still a pre-revenue company, they are clearly starting to tool-up for an expanded assault on the marketplace, which is a recipe that seems to be in prime demand for investors right now. We will update the story again soon as developments transpire. For continuing coverage on shares of $OWCP stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!